Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.

@article{Sheng2007ClinicalIO,
  title={Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.},
  author={Wang-Huei Sheng and Chien-Ching Hung and Ruei-Jiuan Wu and Jann-Tay Wang and Pei-Jer Chen and Shan-Chwen Chang and Jia-Horng Kao},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2007},
  volume={44 4},
  pages={
          584-90
        }
}
BACKGROUND The influence of GB virus C (GBV-C) viremia on clinical outcomes of patients with human immunodeficiency virus type 1 (HIV-1) infection remains controversial in the era of highly active antiretroviral therapy (HAART). METHODS A prospective observational study was conducted to describe the epidemiology of GBV-C viremia and assess its clinical impact on treatment responses to HAART in 385 HIV-1-infected patients during the period from January 1999 through June 2004. RESULTS A total… CONTINUE READING